NGNE SCHEDULE 13G/A: SEC filing

Samsara BioCapital, L.P. and affiliated entities

Filed with the SEC on · accession 0001699737-26-000026

NGNE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -2.6% by the first close after the filing.

Summary of the filing

Samsara BioCapital, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 9.7% of Neurogene Inc.'s common stock as of September 30, 2026, held across Samsara BioCapital LP and Samsara Opportunity Fund.

Key details

Shares of common stock and pre-funded warrants beneficially owned by Samsara BioCapital, L.P.$1.8M
Shares of common stock beneficially owned by Samsara Opportunity Fund, L.P.$150K
Aggregate shares beneficially owned by Srinivas Akkaraju$2.0M
Reporting person / beneficial ownerSamsara BioCapital, L.P.
General partner of samsara biocapital, l.p.Samsara BioCapital GP, LLC
Reporting person / beneficial ownerSamsara Opportunity Fund, L.P.
General partner of samsara opportunity fund, l.p.Samsara Opportunity Fund GP, LLC
IssuerNeurogene Inc.
Managing member of samsara biocapital gp, llc and samsara opportunity fund gp, llcSrinivas Akkaraju

How NGNE stock reacted

Close before

$23.93

Nov 13, 2026

First close after

-2.63%

$23.30

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for NGNE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NGNE?

Click here

Frequently asked questions

What did NGNE file with the SEC on Nov 16, 2026?

NGNE filed a SCHEDULE 13G/A (SEC filing). Samsara BioCapital, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 9.7% of Neurogene Inc.'s common stock as of September 30, 2026, held across Samsara BioCapital LP and Samsara Opportunity Fund.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did NGNE stock react to this filing?

NGNE closed at $23.93 before the filing and $23.30 on Nov 16, 2026 (-2.63%).

Other NGNE SEC filings

Get alerts when NGNE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days